Device Trial Radar · NCT03559322
Real World Experiences of the iNAP® Lite in OSA Adults in Taiwan
Last checked: Nov 20, 2026Latest source record: Sep 23, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
76
Planned (sponsor's estimate)
Start
Aug 1, 2019
Primary completion
Aug 1, 2021
Study completion Dec 30, 2021
Sponsor
- Lead sponsor
- Somnics, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 18, 2018
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Prospective, Observational, Post-market Surveillance Study to Evaluate the Long-term Safety and Efficacy of the iNAP® Lite Sleep Therapy System in Adults with Obstructive Sleep Apnea
Conditions
- Obstructive Sleep Apnea of Adult
Interventions
iNAP® Lite Sleep Therapy SystemDevice
Class II intraoral devices for snoring and/or obstructive sleep apnea
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with adverse events in this entire study.Time frame: through study completion, up to 10 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, Taiwan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.